Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Ideal Cures Pvt Ltd? Find Flixotide Inhaler to address your drug delivery challenges on PharmaCompass.

Flixotide Inhaler

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 29 USDMF, 30 CEP/COS, 6 JDMF, 7 EU WC, 2 KDMF, 27 NDC API, 44 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

49 Drugs in Development

49 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

428 FDF Dossiers, 70 FDA Orange Book, 212 Europe, 32 Canada, 22 Australia, 41 South Africa, 51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 21 Solubilizers, 19 Thickeners and Stabilizers, 19 Topical, 16 Direct Compression, 14 Disintegrants & Superdisintegrants, 13 Parenteral, 12 Granulation, 10 Emulsifying Agents, 10 Co-Processed Excipients, 9 Controlled & Modified Release, 7 Film Formers & Plasticizers, 6 Rheology Modifiers, 6 Coating Systems & Additives, 6 Surfactant & Foaming Agents, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 1 Lubricants & Glidants, 1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 142 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 164 Finished Drug Prices, 12 Annual Reports

MARKET PLACE

16 APIs, 4 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

573 US Patents, 11 US Exclusivities, 53 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 7 USP, 9 Others

$ Xls

Filters

Flixotide Inhaler

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Ideal Cures Pvt Ltd

filter Capability Reset all filters

filter Country Reset all filters

01

Ideal Cures Pvt Ltd

Biotech Digital Meet

Not Confirmed